ANDRULIS PHARMACEUTICALS CORPORATION
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 31, 2000 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 450 Total Citation Count
- Dec 26, 1985 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6140346 Treatment of cancer with thalidomide alone or in combination with other anti-cancer agentsMay 04, 98Oct 31, 00[A61K]
5731325 Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agentsJun 06, 95Mar 24, 98[A61K]
5654312 Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agentsJun 07, 95Aug 05, 97[A61K]
5643915 Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapiesJun 06, 95Jul 01, 97[A61K, A01N]
Expired/Abandoned/Withdrawn Patents
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
